We are analyzing https://link.springer.com/article/10.1007/s10549-005-1483-4.

Title:
GREB1 is a critical regulator of hormone dependent breast cancer growth | Breast Cancer Research and Treatment
Description:
Background Estrogen plays a central role in breast cancer pathogenesis and many potent risk factors for the development of the disease can be explained in terms of increased lifetime exposure to estrogen. Although estrogen regulated genes have been identified, those critically involved in growth regulation remain elusive. Methods. To identify candidate genes involved in estrogen stimulated breast cancer growth, DNA microarray based gene expression profiles were generated from three estrogen receptor α (ERα) positive breast cancer cell lines grown under multiple stimulatory and inhibitory conditions. Results Only three genes were significantly induced by 17β-estradiol (E2) relative to control in all three cell lines: GREB1, stromal cell-derived factor 1 (SDF-1) and trefoil factor 1 (pS2). Quantitative real-time PCR assays confirmed that in all three cell lines, GREB1 was induced by E2, but not by the antiestrogens tamoxifen (TAM) or ICI 182,780. GREB1 expression level was strongly correlated with ERα positivity in 39 breast cancer cell lines of known ERα expression status. GREB1 induction by E2 was rapid (7.3 fold by 2 h for MCF-7) and mirrored the fraction of cells entering S-phase when released from an estrogen deprivation induced cell arrest. Suppression of GREB1 using siRNA blocked estrogen induced growth in MCF-7 cells and caused a paradoxical E2 induced growth inhibition. Conclusion These data suggest that GREB1 is critically involved in the estrogen induced growth of breast cancer cells and has the potential of being a clinical marker for response to endocrine therapy as well as a potential therapeutic target.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,182 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cancer, breast, google, scholar, estrogen, growth, greb, expression, receptor, cells, article, genes, gene, res, cell, factor, human, induced, access, rae, response, privacy, cookies, content, data, research, lippman, lines, tamoxifen, target, usa, mol, endocrinol, profiling, publish, search, johnson, erα, control, mcf, open, receptors, treat, cdna, nature, analysis, information, log, journal, treatment,

Topics {✒️}

real-time quantitative pcr month download article/chapter transforming growth factor-α breast cancer cells cells entering s-phase early estrogen-induced gene human osteosarcoma cells clark-lewis df legler estradiol-independent mrna control pnr-2/ps2 immunohistochemical staining 4-hydroxy-n-desmethyl tamoxifen growth factor pathways breast cancer pathogenesis breast cancer er ps2 gene transcription estrogen induced growth related subjects estrogen-regulated gene expression dunphy po brown estrogen-regulated genes expressed soulez mg parker unidentified human genes stossi jm danes estrogen receptor α estrogen receptor action estrogen receptor β estrogen-responsive genes breast cancer mcf-7 cells brown jm jeltsch schwartz jm heard potent risk factors estrogen regulated genes privacy choices/manage cookies usa james full article pdf trefoil factor 1 regulated gene expression sci 1 frasor jm danes rowlatt tc stephens bessia jl virelizier common target genes model-based analysis lyttle cr katzenellenbogen bs cell lines gene expression profiling check access instant access

Schema {🗺️}

WebPage:
      mainEntity:
         headline:GREB1 is a critical regulator of hormone dependent breast cancer growth
         description:Background Estrogen plays a central role in breast cancer pathogenesis and many potent risk factors for the development of the disease can be explained in terms of increased lifetime exposure to estrogen. Although estrogen regulated genes have been identified, those critically involved in growth regulation remain elusive. Methods. To identify candidate genes involved in estrogen stimulated breast cancer growth, DNA microarray based gene expression profiles were generated from three estrogen receptor α (ERα) positive breast cancer cell lines grown under multiple stimulatory and inhibitory conditions. Results Only three genes were significantly induced by 17β-estradiol (E2) relative to control in all three cell lines: GREB1, stromal cell-derived factor 1 (SDF-1) and trefoil factor 1 (pS2). Quantitative real-time PCR assays confirmed that in all three cell lines, GREB1 was induced by E2, but not by the antiestrogens tamoxifen (TAM) or ICI 182,780. GREB1 expression level was strongly correlated with ERα positivity in 39 breast cancer cell lines of known ERα expression status. GREB1 induction by E2 was rapid (7.3 fold by 2 h for MCF-7) and mirrored the fraction of cells entering S-phase when released from an estrogen deprivation induced cell arrest. Suppression of GREB1 using siRNA blocked estrogen induced growth in MCF-7 cells and caused a paradoxical E2 induced growth inhibition. Conclusion These data suggest that GREB1 is critically involved in the estrogen induced growth of breast cancer cells and has the potential of being a clinical marker for response to endocrine therapy as well as a potential therapeutic target.
         datePublished:
         dateModified:
         pageStart:141
         pageEnd:149
         sameAs:https://doi.org/10.1007/s10549-005-1483-4
         keywords:
            breast cancer
            estrogen induced growth
            GREB1
            hormonal control
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:92
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:James M. Rae
               affiliation:
                     name:University of Michigan Medical Center
                     address:
                        name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               email: [email protected]
               type:Person
               name:Michael D. Johnson
               affiliation:
                     name:Georgetown University
                     address:
                        name:Department of Oncology, Georgetown University, Washington
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joshua O. Scheys
               affiliation:
                     name:University of Michigan Medical Center
                     address:
                        name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kevin E. Cordero
               affiliation:
                     name:University of Michigan Medical Center
                     address:
                        name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:José M. Larios
               affiliation:
                     name:University of Michigan Medical Center
                     address:
                        name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marc E. Lippman
               affiliation:
                     name:University of Michigan Medical Center
                     address:
                        name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:GREB1 is a critical regulator of hormone dependent breast cancer growth
      description:Background Estrogen plays a central role in breast cancer pathogenesis and many potent risk factors for the development of the disease can be explained in terms of increased lifetime exposure to estrogen. Although estrogen regulated genes have been identified, those critically involved in growth regulation remain elusive. Methods. To identify candidate genes involved in estrogen stimulated breast cancer growth, DNA microarray based gene expression profiles were generated from three estrogen receptor α (ERα) positive breast cancer cell lines grown under multiple stimulatory and inhibitory conditions. Results Only three genes were significantly induced by 17β-estradiol (E2) relative to control in all three cell lines: GREB1, stromal cell-derived factor 1 (SDF-1) and trefoil factor 1 (pS2). Quantitative real-time PCR assays confirmed that in all three cell lines, GREB1 was induced by E2, but not by the antiestrogens tamoxifen (TAM) or ICI 182,780. GREB1 expression level was strongly correlated with ERα positivity in 39 breast cancer cell lines of known ERα expression status. GREB1 induction by E2 was rapid (7.3 fold by 2 h for MCF-7) and mirrored the fraction of cells entering S-phase when released from an estrogen deprivation induced cell arrest. Suppression of GREB1 using siRNA blocked estrogen induced growth in MCF-7 cells and caused a paradoxical E2 induced growth inhibition. Conclusion These data suggest that GREB1 is critically involved in the estrogen induced growth of breast cancer cells and has the potential of being a clinical marker for response to endocrine therapy as well as a potential therapeutic target.
      datePublished:
      dateModified:
      pageStart:141
      pageEnd:149
      sameAs:https://doi.org/10.1007/s10549-005-1483-4
      keywords:
         breast cancer
         estrogen induced growth
         GREB1
         hormonal control
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:92
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:James M. Rae
            affiliation:
                  name:University of Michigan Medical Center
                  address:
                     name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            email: [email protected]
            type:Person
            name:Michael D. Johnson
            affiliation:
                  name:Georgetown University
                  address:
                     name:Department of Oncology, Georgetown University, Washington
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joshua O. Scheys
            affiliation:
                  name:University of Michigan Medical Center
                  address:
                     name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kevin E. Cordero
            affiliation:
                  name:University of Michigan Medical Center
                  address:
                     name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:José M. Larios
            affiliation:
                  name:University of Michigan Medical Center
                  address:
                     name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marc E. Lippman
            affiliation:
                  name:University of Michigan Medical Center
                  address:
                     name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:92
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Michigan Medical Center
      address:
         name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
         type:PostalAddress
      name:Georgetown University
      address:
         name:Department of Oncology, Georgetown University, Washington
         type:PostalAddress
      name:University of Michigan Medical Center
      address:
         name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
         type:PostalAddress
      name:University of Michigan Medical Center
      address:
         name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
         type:PostalAddress
      name:University of Michigan Medical Center
      address:
         name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
         type:PostalAddress
      name:University of Michigan Medical Center
      address:
         name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:James M. Rae
      affiliation:
            name:University of Michigan Medical Center
            address:
               name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      email: [email protected]
      name:Michael D. Johnson
      affiliation:
            name:Georgetown University
            address:
               name:Department of Oncology, Georgetown University, Washington
               type:PostalAddress
            type:Organization
      name:Joshua O. Scheys
      affiliation:
            name:University of Michigan Medical Center
            address:
               name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      name:Kevin E. Cordero
      affiliation:
            name:University of Michigan Medical Center
            address:
               name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      name:José M. Larios
      affiliation:
            name:University of Michigan Medical Center
            address:
               name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      name:Marc E. Lippman
      affiliation:
            name:University of Michigan Medical Center
            address:
               name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
      name:Department of Oncology, Georgetown University, Washington
      name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
      name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
      name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
      name:Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(65)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.31s.

LINK . SPRINGER . COM {}